Details
Stereochemistry | ACHIRAL |
Molecular Formula | C6H6N2O |
Molecular Weight | 122.1246 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC(=O)C1=CN=CC=C1
InChI
InChIKey=DFPAKSUCGFBDDF-UHFFFAOYSA-N
InChI=1S/C6H6N2O/c7-6(9)5-2-1-3-8-4-5/h1-4H,(H2,7,9)
Molecular Formula | C6H6N2O |
Molecular Weight | 122.1246 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:23:22 UTC 2023
by
admin
on
Fri Dec 15 15:23:22 UTC 2023
|
Record UNII |
25X51I8RD4
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
A11HA01
Created by
admin on Fri Dec 15 15:23:22 UTC 2023 , Edited by admin on Fri Dec 15 15:23:22 UTC 2023
|
||
|
DSLD |
2664 (Number of products:4764)
Created by
admin on Fri Dec 15 15:23:22 UTC 2023 , Edited by admin on Fri Dec 15 15:23:22 UTC 2023
|
||
|
NCI_THESAURUS |
C26017
Created by
admin on Fri Dec 15 15:23:22 UTC 2023 , Edited by admin on Fri Dec 15 15:23:22 UTC 2023
|
||
|
LIVERTOX |
681
Created by
admin on Fri Dec 15 15:23:22 UTC 2023 , Edited by admin on Fri Dec 15 15:23:22 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
27
Created by
admin on Fri Dec 15 15:23:22 UTC 2023 , Edited by admin on Fri Dec 15 15:23:22 UTC 2023
|
||
|
NCI_THESAURUS |
C275
Created by
admin on Fri Dec 15 15:23:22 UTC 2023 , Edited by admin on Fri Dec 15 15:23:22 UTC 2023
|
||
|
DSLD |
1097 (Number of products:12)
Created by
admin on Fri Dec 15 15:23:22 UTC 2023 , Edited by admin on Fri Dec 15 15:23:22 UTC 2023
|
||
|
CFR |
21 CFR 184.1535
Created by
admin on Fri Dec 15 15:23:22 UTC 2023 , Edited by admin on Fri Dec 15 15:23:22 UTC 2023
|
||
|
DSLD |
204 (Number of products:661)
Created by
admin on Fri Dec 15 15:23:22 UTC 2023 , Edited by admin on Fri Dec 15 15:23:22 UTC 2023
|
||
|
WHO-VATC |
QA11HA01
Created by
admin on Fri Dec 15 15:23:22 UTC 2023 , Edited by admin on Fri Dec 15 15:23:22 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
202-713-4
Created by
admin on Fri Dec 15 15:23:22 UTC 2023 , Edited by admin on Fri Dec 15 15:23:22 UTC 2023
|
PRIMARY | |||
|
13128
Created by
admin on Fri Dec 15 15:23:22 UTC 2023 , Edited by admin on Fri Dec 15 15:23:22 UTC 2023
|
PRIMARY | |||
|
7405
Created by
admin on Fri Dec 15 15:23:22 UTC 2023 , Edited by admin on Fri Dec 15 15:23:22 UTC 2023
|
PRIMARY | RxNorm | ||
|
1237
Created by
admin on Fri Dec 15 15:23:22 UTC 2023 , Edited by admin on Fri Dec 15 15:23:22 UTC 2023
|
PRIMARY | |||
|
25X51I8RD4
Created by
admin on Fri Dec 15 15:23:22 UTC 2023 , Edited by admin on Fri Dec 15 15:23:22 UTC 2023
|
PRIMARY | |||
|
D009536
Created by
admin on Fri Dec 15 15:23:22 UTC 2023 , Edited by admin on Fri Dec 15 15:23:22 UTC 2023
|
PRIMARY | |||
|
404
Created by
admin on Fri Dec 15 15:23:22 UTC 2023 , Edited by admin on Fri Dec 15 15:23:22 UTC 2023
|
PRIMARY | |||
|
27452
Created by
admin on Fri Dec 15 15:23:22 UTC 2023 , Edited by admin on Fri Dec 15 15:23:22 UTC 2023
|
PRIMARY | |||
|
936
Created by
admin on Fri Dec 15 15:23:22 UTC 2023 , Edited by admin on Fri Dec 15 15:23:22 UTC 2023
|
PRIMARY | |||
|
C2327
Created by
admin on Fri Dec 15 15:23:22 UTC 2023 , Edited by admin on Fri Dec 15 15:23:22 UTC 2023
|
PRIMARY | |||
|
NICOTINAMIDE
Created by
admin on Fri Dec 15 15:23:22 UTC 2023 , Edited by admin on Fri Dec 15 15:23:22 UTC 2023
|
PRIMARY | |||
|
98-92-0
Created by
admin on Fri Dec 15 15:23:22 UTC 2023 , Edited by admin on Fri Dec 15 15:23:22 UTC 2023
|
PRIMARY | |||
|
DTXSID2020929
Created by
admin on Fri Dec 15 15:23:22 UTC 2023 , Edited by admin on Fri Dec 15 15:23:22 UTC 2023
|
PRIMARY | |||
|
DB02701
Created by
admin on Fri Dec 15 15:23:22 UTC 2023 , Edited by admin on Fri Dec 15 15:23:22 UTC 2023
|
PRIMARY | |||
|
1906
Created by
admin on Fri Dec 15 15:23:22 UTC 2023 , Edited by admin on Fri Dec 15 15:23:22 UTC 2023
|
PRIMARY | |||
|
100000092193
Created by
admin on Fri Dec 15 15:23:22 UTC 2023 , Edited by admin on Fri Dec 15 15:23:22 UTC 2023
|
PRIMARY | |||
|
NIACINAMIDE
Created by
admin on Fri Dec 15 15:23:22 UTC 2023 , Edited by admin on Fri Dec 15 15:23:22 UTC 2023
|
PRIMARY | Description: Colourless crystals or a white, crystalline powder; odourless or almost odourless. Solubility: Soluble in 1 part of water and 2 parts of ethanol (~750 g/l) TS; slightly soluble in ether R. Category: Vitamin. Storage: Nicotinamide should be kept in a well-closed container. Definition: Nicotinamide contains not less than 99.0% and not more than 101.0% of C6H6N2O, calculated with reference to thedried substance. | ||
|
m7878
Created by
admin on Fri Dec 15 15:23:22 UTC 2023 , Edited by admin on Fri Dec 15 15:23:22 UTC 2023
|
PRIMARY | Merck Index | ||
|
1462006
Created by
admin on Fri Dec 15 15:23:22 UTC 2023 , Edited by admin on Fri Dec 15 15:23:22 UTC 2023
|
PRIMARY | |||
|
25X51I8RD4
Created by
admin on Fri Dec 15 15:23:22 UTC 2023 , Edited by admin on Fri Dec 15 15:23:22 UTC 2023
|
PRIMARY | |||
|
SUB09246MIG
Created by
admin on Fri Dec 15 15:23:22 UTC 2023 , Edited by admin on Fri Dec 15 15:23:22 UTC 2023
|
PRIMARY | |||
|
17154
Created by
admin on Fri Dec 15 15:23:22 UTC 2023 , Edited by admin on Fri Dec 15 15:23:22 UTC 2023
|
PRIMARY | |||
|
CHEMBL1140
Created by
admin on Fri Dec 15 15:23:22 UTC 2023 , Edited by admin on Fri Dec 15 15:23:22 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
TARGET -> INHIBITOR |
NAD-dependent lysine desuccinylase activity is inhibited by physiological nicotinamide concentrations, while deacetylase activity is not.
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE ACTIVE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |